NDC 0591-3355

Nateglinide

Nateglinide

Nateglinide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Nateglinide.

Product ID0591-3355_ead87332-2796-4cae-b377-5e54aae8a3ae
NDC0591-3355
Product TypeHuman Prescription Drug
Proprietary NameNateglinide
Generic NameNateglinide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-05-18
Marketing CategoryANDA / ANDA
Application NumberANDA077462
Labeler NameActavis Pharma, Inc.
Substance NameNATEGLINIDE
Active Ingredient Strength120 mg/1
Pharm ClassesGlinide [EPC],Potassium Channel Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0591-3355-01

100 TABLET in 1 BOTTLE, PLASTIC (0591-3355-01)
Marketing Start Date2011-05-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-3355-10 [00591335510]

Nateglinide TABLET
Marketing CategoryANDA
Application NumberANDA077462
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-05-18
Marketing End Date2011-05-18

NDC 0591-3355-30 [00591335530]

Nateglinide TABLET
Marketing CategoryANDA
Application NumberANDA077462
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-05-18
Marketing End Date2011-05-18

NDC 0591-3355-01 [00591335501]

Nateglinide TABLET
Marketing CategoryANDA
Application NumberANDA077462
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-05-18

Drug Details

Active Ingredients

IngredientStrength
NATEGLINIDE120 mg/1

OpenFDA Data

SPL SET ID:a7e9f62e-32f8-4a89-8588-74d029c8f6a2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311919
  • 314142

    • Pharmacological Class

    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]
    • Glinide [EPC]
    • Potassium Channel Antagonists [MoA]

    NDC Crossover Matching brand name "Nateglinide" or generic name "Nateglinide"

    NDCBrand NameGeneric Name
    0591-3354NateglinideNateglinide
    0591-3355NateglinideNateglinide
    0615-7585NateglinideNateglinide
    0615-7586NateglinideNateglinide
    16571-758NATEGLINIDENATEGLINIDE
    16571-759NATEGLINIDENATEGLINIDE
    42291-636NateglinideNateglinide
    42291-637NateglinideNateglinide
    49884-984NateglinideNateglinide
    49884-985NateglinideNateglinide
    51407-656Nateglinidenateglinide
    51407-657Nateglinidenateglinide
    52536-063NateglinideNateglinide
    52536-067NateglinideNateglinide
    55111-328NateglinideNateglinide
    55111-329NateglinideNateglinide
    60429-434NateglinideNateglinide
    60429-435NateglinideNateglinide
    60687-673Nateglinidenateglinide
    60687-684Nateglinidenateglinide
    64380-167Nateglinidenateglinide
    64380-168Nateglinidenateglinide
    68084-458NateglinideNateglinide
    68084-459NateglinideNateglinide
    68382-721NateglinideNateglinide
    68382-722NateglinideNateglinide
    70771-1016NateglinideNateglinide
    70771-1015NateglinideNateglinide
    71209-030NateglinideNateglinide
    71209-031NateglinideNateglinide
    75834-205NATEGLINIDENATEGLINIDE
    75834-206NATEGLINIDENATEGLINIDE
    0078-0351Starlixnateglinide
    0078-0352Starlixnateglinide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.